Clinical response to oral tofacitinib in pediatric patients with alopecia areata

Clinical response to oral tofacitinib in pediatric patients with alopecia areata

Bibliographic Details
Main Authors:	Soundos Youssef, MD, Lindsey A. Bordone, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	JAAD Case Reports
Subjects:	alopecia areata JAK inhibitor Janus kinase inhibitor oral tofacitinib pediatric population treatment efficacy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622003800

Similar Items

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016-04-01)

Effective treatment of alopecia universalis with oral upadacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
by: Ying-Xiu Dai, et al.
Published: (2020-01-01)

Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
by: Siddhi B. Chikhalkar, et al.
Published: (2024-06-01)

Two cases of bullous pemphigoid effectively treated with oral tofacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-02-01)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)

Modern Management Approaches for Alopecia Areata
by: Eduard T. Ambarchyan, et al.
Published: (2024-12-01)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022-11-01)

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
by: Wenxin Zhang, et al.
Published: (2022-06-01)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020-05-01)

Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
by: Sophia A. Ederaine, BA, et al.
Published: (2022-02-01)

Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
by: Zoe Apalla, et al.
Published: (2024-04-01)

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023-11-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
by: Danielle M. Peterson, MD, et al.
Published: (2021-01-01)

Short-term efficacy and safety of tofacitinib in the treatment of alopecia areata
by: Zuyan WANG, et al.
Published: (2024-02-01)

An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
by: Rachel Berbert Ferreira, et al.
Published: (2019-12-01)

Tofacitinib in a Recalcitrant Case of Alopecia Areata
by: Mansi Pithadia, et al.
Published: (2022-12-01)

Peripheral neuropathy associated with tofacitinib use in alopecia universalis
by: Raghad Alharthi, et al.
Published: (2022-01-01)

Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
by: C. Garcia-Melendo, et al.
Published: (2021-06-01)

Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
by: Zhou J, et al.
Published: (2023-10-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)

Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib
by: Sa Rang Kim, MD, et al.
Published: (2021-10-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus
by: Soundos Youssef, MD, et al.
Published: (2023-07-01)

Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
by: Sineida Berbert Ferreira, et al.
Published: (2016-10-01)

Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
by: Dongfan Wei, et al.
Published: (2023-04-01)

Oral tofacitinib: Contemporary appraisal of its role in dermatology
by: Sidharth Sonthalia, et al.
Published: (2019-01-01)

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01)

Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
by: Jundong Huang, et al.
Published: (2023-09-01)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01)

The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
by: Tomasz Skrzypczak, et al.
Published: (2024-11-01)

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
by: Alexander Egeberg, et al.
Published: (2023-10-01)

Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
by: Matteini E, et al.
Published: (2024-10-01)

Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
by: Ling Yu, et al.
Published: (2022-06-01)

Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
by: Danielle M. Peterson, MD, et al.
Published: (2020-04-01)

Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
by: Jundong Huang, et al.
Published: (2023-10-01)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021-01-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023-01-01)